目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table 0A : Global Market for Pulmonary Drug Delivery Systems, by Type, Through 2027
Figure Summary : Global Market for Pulmonary Drug Delivery Systems, by Type, 2019-2027
Table 0B : Global Market for Pulmonary Drug Delivery Systems, by Region, Through 2027

Chapter- 3: Market Dynamics and Technology Background
Market Definition and Overview
Pulmonary Conditions and Therapies
Market Drivers and Trends
Market Restraints
Market Opportunities
Regulation and Legislation

Chapter- 4: Market Breakdown by Pulmonary Drug Delivery Systems
Overview of Inhalation Techniques
Dry Powder Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Nebulizers

Chapter- 5: COVID-19 Impact
Overview
COVID-19 Crisis
Impact on Market for Pulmonary Drug Delivery Systems
Current Outlook

Chapter- 6: Pulmonary Drug Delivery Systems in Use
Therapeutic Agents Administered via Inhalation

Chapter- 7: Market Breakdown by Disease Area
Introduction
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Other Diseases

Chapter- 8: Market Breakdown by Region
North America
Europe
Asia-Pacific
Rest of the World
South America

Chapter- 9: Patent Analysis
Overview

Chapter- 10: Company Profiles
3M
ABBOTT LABORATORIES
ASTRAZENECA
BOEHRINGER INGELHEIM GMBH
CIPLA
DR. REDDY'S LABORATORIES LTD.
GLAXOSMITHKLINE PLC
PHILIPS RESPIRONICS
LUPIN
MYLAN N.V.
MERCK KGAA
NOVARTIS AG
OMRON CORP.
PFIZER INC.
PULMATRIX INC.
TEVA PHARMACEUTICALS INDUSTRIES LTD.

Chapter- 11: Appendix: Abbreviations
Table 42 : Abbreviations Used in Pulmonary Drug Delivery Systems